FDA Inspection 732886 — Hospira, Inc.

Hospira, Inc. — FEI 1021343

The FDA completed an inspection of Hospira, Inc. on June 17, 2011 in Rocky Mount, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 17 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 17, 2011
Fiscal Year
2011
Product Type
Devices
Project Area
Compliance: Devices
Location
Rocky Mount, NC (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
117721 CFR 211.63Equipment Design, Size and Location
119421 CFR 211.42(c)Defined areas of adequate size for operations
121521 CFR 211.67(b)Written procedures not established/followed
191421 CFR 211.166(a)Lack of written stability program
202721 CFR 211.192Investigations of discrepancies, failures
202821 CFR 211.192Extent of discrepancy, failure investigations
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
243021 CFR 820.30(b)Design plans - Lack of or inadequate
311821 CFR 820.75(a)Documentation
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360221 CFR 211.160(a)Deviations from laboratory control requirements
366921 CFR 820.20(c)Management review - defined interval, sufficient frequency
440221 CFR 211.192Written record of investigation incomplete
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications